Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Up – Still a Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares gapped up prior to trading on Friday . The stock had previously closed at $9.56, but opened at $10.04. Nihon Kohden shares last traded at $10.03, with a volume of 1,526 shares changing hands.

Wall Street Analyst Weigh In

Separately, UBS Group downgraded Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 12th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.

Nihon Kohden Price Performance

The stock has a market cap of $1.68 billion, a price-to-earnings ratio of 18.21 and a beta of 0.36. The company’s 50 day moving average is $9.49 and its 200 day moving average is $9.40.

Nihon Kohden (OTCMKTS:NHNKY) last issued its earnings results on Thursday, August 6th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.09). Nihon Kohden had a return on equity of 9.08% and a net margin of 5.90%.The company had revenue of $297.47 million for the quarter, compared to analyst estimates of $299.98 million. Sell-side analysts predict that Nihon Kohden Corporation will post 0.6 earnings per share for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.